Cefixime | Interleukin Related interleukin-related.com

Product Name :
Cefixime

Search keywords :
Cefixime

drugId :
null

Target Vo:
Bacterial penicillin-binding protein

Target Vo Short Name :
PBPs

Moa_Name:
Bacterial penicillin-binding protein inhibitors

First Approval Country :

First Approval Date Filter:
1987

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Guangzhou Baiyunshan Pharmaceutical Co Ltd Guangzhou Baiyunshan Pharmaceutical General

Active Indication_Name:
Bacterial Infections

In Active Indication_Name:
Tonsillitis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Proteasome beta 8 (Y10P74) Mouse mAb supplier
FGFR1 Rabbit mAb Epigenetic Reader Domain
MMP1 Antibody: MMP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to MMP1. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts